U.S., July 9 -- ClinicalTrials.gov registry received information related to the study (NCT07054541) titled 'CliNical Study on UltrasOund-guided Percutaneous InterVention for AtriAl Septal Defect With the Assistance of Specialized Instruments' on June 17.
Brief Summary: Atrial septal defect (ASD) is a common congenital heart disease, and percutaneous interventional therapy is the main and effective treatment. Traditional percutaneous closure procedures are performed under fluoroscopic guidance and require contrast agents. A retrospective analysis of over 20,000 adult patients with congenital heart disease revealed that even low-dose radiation exposure was significantly associated with an increased long-term risk of malignancy. Moreover, the...